Copyright Reports & Markets. All rights reserved.

Global Ankylosing Spondylitis Drug Market Research Report 2019

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Ankylosing Spondylitis Drug Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Cimzia
    • 1.4.3 Enbrel
    • 1.4.4 Humira
    • 1.4.5 Remicade
    • 1.4.6 Simponi
    • 1.4.7 Others
  • 1.5 Market by Application
    • 1.5.1 Global Ankylosing Spondylitis Drug Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Ankylosing Spondylitis Drug Market Perspective (2015-2026)
  • 2.2 Global Ankylosing Spondylitis Drug Growth Trends by Regions
    • 2.2.1 Ankylosing Spondylitis Drug Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Ankylosing Spondylitis Drug Historic Market Share by Regions (2015-2020)
    • 2.2.3 Ankylosing Spondylitis Drug Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Ankylosing Spondylitis Drug Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Ankylosing Spondylitis Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Ankylosing Spondylitis Drug Players by Market Size
    • 3.1.1 Global Top Ankylosing Spondylitis Drug Players by Revenue (2015-2020)
    • 3.1.2 Global Ankylosing Spondylitis Drug Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Ankylosing Spondylitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Ankylosing Spondylitis Drug Market Concentration Ratio
    • 3.2.1 Global Ankylosing Spondylitis Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Ankylosing Spondylitis Drug Revenue in 2019
  • 3.3 Ankylosing Spondylitis Drug Key Players Head office and Area Served
  • 3.4 Key Players Ankylosing Spondylitis Drug Product Solution and Service
  • 3.5 Date of Enter into Ankylosing Spondylitis Drug Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Ankylosing Spondylitis Drug Historic Market Size by Type (2015-2020)
  • 4.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Ankylosing Spondylitis Drug Market Size by Application (2015-2020)
  • 5.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Ankylosing Spondylitis Drug Market Size (2015-2020)
  • 6.2 Ankylosing Spondylitis Drug Key Players in North America (2019-2020)
  • 6.3 North America Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
  • 6.4 North America Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Ankylosing Spondylitis Drug Market Size (2015-2020)
  • 7.2 Ankylosing Spondylitis Drug Key Players in Europe (2019-2020)
  • 7.3 Europe Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
  • 7.4 Europe Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

8 China

  • 8.1 China Ankylosing Spondylitis Drug Market Size (2015-2020)
  • 8.2 Ankylosing Spondylitis Drug Key Players in China (2019-2020)
  • 8.3 China Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
  • 8.4 China Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Ankylosing Spondylitis Drug Market Size (2015-2020)
  • 9.2 Ankylosing Spondylitis Drug Key Players in Japan (2019-2020)
  • 9.3 Japan Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
  • 9.4 Japan Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Ankylosing Spondylitis Drug Market Size (2015-2020)
  • 10.2 Ankylosing Spondylitis Drug Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

11 India

  • 11.1 India Ankylosing Spondylitis Drug Market Size (2015-2020)
  • 11.2 Ankylosing Spondylitis Drug Key Players in India (2019-2020)
  • 11.3 India Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
  • 11.4 India Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Ankylosing Spondylitis Drug Market Size (2015-2020)
  • 12.2 Ankylosing Spondylitis Drug Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
  • 12.4 Central & South America Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Amgen
    • 13.1.1 Amgen Company Details
    • 13.1.2 Amgen Business Overview
    • 13.1.3 Amgen Ankylosing Spondylitis Drug Introduction
    • 13.1.4 Amgen Revenue in Ankylosing Spondylitis Drug Business (2015-2020))
    • 13.1.5 Amgen Recent Development
  • 13.2 Wyeth
    • 13.2.1 Wyeth Company Details
    • 13.2.2 Wyeth Business Overview
    • 13.2.3 Wyeth Ankylosing Spondylitis Drug Introduction
    • 13.2.4 Wyeth Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
    • 13.2.5 Wyeth Recent Development
  • 13.3 Takeda
    • 13.3.1 Takeda Company Details
    • 13.3.2 Takeda Business Overview
    • 13.3.3 Takeda Ankylosing Spondylitis Drug Introduction
    • 13.3.4 Takeda Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
    • 13.3.5 Takeda Recent Development
  • 13.4 Centocor
    • 13.4.1 Centocor Company Details
    • 13.4.2 Centocor Business Overview
    • 13.4.3 Centocor Ankylosing Spondylitis Drug Introduction
    • 13.4.4 Centocor Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
    • 13.4.5 Centocor Recent Development
  • 13.5 Schering-Plough
    • 13.5.1 Schering-Plough Company Details
    • 13.5.2 Schering-Plough Business Overview
    • 13.5.3 Schering-Plough Ankylosing Spondylitis Drug Introduction
    • 13.5.4 Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
    • 13.5.5 Schering-Plough Recent Development
  • 13.6 Mitsubishi Tanabe
    • 13.6.1 Mitsubishi Tanabe Company Details
    • 13.6.2 Mitsubishi Tanabe Business Overview
    • 13.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Introduction
    • 13.6.4 Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
    • 13.6.5 Mitsubishi Tanabe Recent Development
  • 13.7 Abbott
    • 13.7.1 Abbott Company Details
    • 13.7.2 Abbott Business Overview
    • 13.7.3 Abbott Ankylosing Spondylitis Drug Introduction
    • 13.7.4 Abbott Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
    • 13.7.5 Abbott Recent Development
  • 13.8 Eisai
    • 13.8.1 Eisai Company Details
    • 13.8.2 Eisai Business Overview
    • 13.8.3 Eisai Ankylosing Spondylitis Drug Introduction
    • 13.8.4 Eisai Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
    • 13.8.5 Eisai Recent Development
  • 13.9 Pfizer
    • 13.9.1 Pfizer Company Details
    • 13.9.2 Pfizer Business Overview
    • 13.9.3 Pfizer Ankylosing Spondylitis Drug Introduction
    • 13.9.4 Pfizer Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
    • 13.9.5 Pfizer Recent Development
  • 13.10 Johnson & Johnson
    • 13.10.1 Johnson & Johnson Company Details
    • 13.10.2 Johnson & Johnson Business Overview
    • 13.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Introduction
    • 13.10.4 Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
    • 13.10.5 Johnson & Johnson Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Ankylosing Spondylitis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ankylosing Spondylitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Amgen
    Wyeth
    Takeda
    Centocor
    Schering-Plough
    Mitsubishi Tanabe
    Abbott
    Eisai
    Pfizer
    Johnson & Johnson

    Market segment by Type, the product can be split into
    Cimzia
    Enbrel
    Humira
    Remicade
    Simponi
    Others
    Market segment by Application, split into
    Hospitals
    Clinics

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now